Streamlining Post-Authorization Changes: Key Updates to the EU Pharmaceutical Variation Guidelines
Streamlining Post-Authorization Changes: Key Updates to the EU Pharmaceutical Variation Guidelines As part of the 2020 Pharmaceutical Strategy for Europe, the Commission is reviewing the current rules governing the procedures for post-authorization changes to the terms of a marketing authorization for medicines products for human use, with the purpose to make the lifecycle